Multidrug and toxin extrusion protein 1
Details
- Name
- Multidrug and toxin extrusion protein 1
- Synonyms
- MATE-1
- MATE1
- Solute carrier family 47 member 1
- Gene Name
- SLC47A1
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0007028|Multidrug and toxin extrusion protein 1 MEAPEEPAPVRGGPEATLEVRGSRCLRLSAFREELRALLVLAGPAFLVQLMVFLISFISS VFCGHLGKLELDAVTLAIAVINVTGVSVGFGLSSACDTLISQTYGSQNLKHVGVILQRSA LVLLLCCFPCWALFLNTQHILLLFRQDPDVSRLTQTYVTIFIPALPATFLYMLQVKYLLN QGIVLPQIVTGVAANLVNALANYLFLHQLHLGVIGSALANLISQYTLALLLFLYILGKKL HQATWGGWSLECLQDWASFLRLAIPSMLMLCMEWWAYEVGSFLSGILGMVELGAQSIVYE LAIIVYMVPAGFSVAASVRVGNALGAGDMEQARKSSTVSLLITVLFAVAFSVLLLSCKDH VGYIFTTDRDIINLVAQVVPIYAVSHLFEALACTSGGVLRGSGNQKVGAIVNTIGYYVVG LPIGIALMFATTLGVMGLWSGIIICTVFQAVCFLGFIIQLNWKKACQQAQVHANLKVNNV PRSGNSALPQDPLHPGCPENLEGILTNDVGKTGEPQSDQQMRQEEPLPEHPQDGAKLSRK QLVLRRGLLLLGVFLILLVGILVRFYVRIQ
- Number of residues
- 570
- Molecular Weight
- 61921.585
- Theoretical pI
- 7.62
- GO Classification
- Functionsdrug transmembrane transporter activity / monovalent cationProcessesdrug transmembrane transport / organic cation transport / transmembrane transportComponentsintegral component of membrane / membrane-bounded vesicle / plasma membrane
- General Function
- Monovalent cation:proton antiporter activity
- Specific Function
- Solute transporter for tetraethylammonium (TEA), 1-methyl-4-phenylpyridinium (MPP), cimetidine, N-methylnicotinamide (NMN), metformin, creatinine, guanidine, procainamide, topotecan, estrone sulfate, acyclovir, ganciclovir and also the zwitterionic cephalosporin, cephalexin and cephradin. Seems to also play a role in the uptake of oxaliplatin (a new platinum anticancer agent). Able to transport paraquat (PQ or N,N-dimethyl-4-4'-bipiridinium); a widely used herbicid. Responsible for the secretion of cationic drugs across the brush border membranes.
- Pfam Domain Function
- MatE (PF01554)
- Transmembrane Regions
- 38-58 73-93 124-144 153-173 177-197 217-237 257-276 296-316 337-357 371-391 409-429 438-458 547-567
- Cellular Location
- Cell membrane
- Gene sequence
>lcl|BSEQ0017174|Multidrug and toxin extrusion protein 1 (SLC47A1) ATGGAAGCTCCTGAGGAGCCCGCGCCAGTGCGCGGAGGCCCGGAGGCCACCCTTGAGGTC CGTGGGTCGCGCTGCTTGCGGCTGTCCGCCTTCCGAGAAGAGCTGCGGGCGCTCTTGGTC CTGGCTGGCCCCGCGTTCTTGGTTCAGCTGATGGTGTTCCTGATCAGCTTCATAAGCTCC GTGTTCTGTGGCCACCTGGGCAAGCTGGAGCTGGATGCAGTCACGCTGGCAATCGCGGTT ATCAATGTCACTGGTGTCTCAGTGGGATTCGGCTTATCTTCTGCCTGTGACACCCTCATC TCCCAGACGTACGGGAGCCAGAACCTGAAGCACGTGGGCGTGATCCTGCAGCGGAGTGCG CTCGTCCTGCTCCTCTGCTGCTTCCCCTGCTGGGCGCTCTTTCTCAACACCCAGCACATC CTGCTGCTCTTCAGGCAGGACCCAGATGTGTCCAGGCTTACCCAGACCTATGTCACGATC TTCATTCCAGCTCTTCCTGCAACCTTTCTTTATATGTTACAAGTTAAATATTTGCTCAAC CAGGGAATTGTACTGCCCCAGATCGTAACTGGAGTTGCAGCCAACCTTGTCAATGCCCTC GCCAACTATCTGTTTCTCCATCAACTGCATCTTGGGGTGATAGGCTCTGCACTGGCAAAC TTGATTTCCCAGTACACCCTGGCTCTACTCCTCTTTCTCTACATCCTCGGGAAAAAACTG CATCAAGCTACATGGGGAGGCTGGTCCCTCGAGTGCCTGCAGGACTGGGCCTCCTTCCTC CGCCTGGCCATCCCCAGCATGCTCATGCTGTGCATGGAGTGGTGGGCCTATGAGGTCGGG AGCTTCCTCAGTGGCATCCTCGGCATGGTGGAGCTGGGCGCTCAGTCCATCGTGTATGAA CTGGCCATCATTGTGTACATGGTCCCTGCAGGCTTCAGTGTGGCTGCCAGTGTCCGGGTA GGAAACGCTCTGGGTGCTGGAGACATGGAGCAGGCACGGAAGTCCTCTACCGTTTCCCTG CTGATTACAGTGCTCTTTGCTGTAGCCTTCAGTGTCCTGCTGTTAAGCTGTAAGGATCAC GTGGGGTACATTTTTACTACCGACCGAGACATCATTAATCTGGTGGCTCAGGTGGTTCCA ATTTATGCTGTTTCCCACCTCTTTGAAGCTCTTGCTTGCACGAGTGGTGGTGTTCTGAGG GGGAGTGGAAATCAGAAGGTTGGAGCCATTGTGAATACCATTGGGTACTATGTGGTTGGC CTCCCCATCGGGATCGCGCTGATGTTTGCAACCACACTTGGAGTGATGGGTCTGTGGTCA GGGATCATCATCTGTACAGTCTTTCAAGCTGTGTGTTTTCTAGGCTTTATTATTCAGCTA AATTGGAAAAAAGCCTGTCAGCAGGCTCAGGTACACGCCAATTTGAAAGTAAACAACGTG CCTCGGAGTGGGAATTCTGCTCTCCCTCAGGATCCGCTTCACCCAGGGTGCCCTGAAAAC CTTGAAGGAATTTTAACGAACGATGTTGGAAAGACAGGCGAGCCTCAGTCAGATCAGCAG ATGCGCCAAGAAGAACCTTTGCCGGAACATCCACAGGACGGCGCTAAATTGTCCAGGAAA CAGCTGGTGCTGCGGCGAGGGCTTCTGCTCCTGGGGGTCTTCTTAATCTTGCTGGTGGGG ATTTTAGTGAGATTCTATGTCAGAATTCAGTGA
- Chromosome Location
- 17
- Locus
- 17p11.2
- External Identifiers
Resource Link UniProtKB ID Q96FL8 UniProtKB Entry Name S47A1_HUMAN GenBank Protein ID 7023138 GenBank Gene ID AK001709 HGNC ID HGNC:25588 - General References
- Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article]
- Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article]
- Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, Moriyama Y: A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):17923-8. Epub 2005 Dec 5. [Article]
- Hiasa M, Matsumoto T, Komatsu T, Moriyama Y: Wide variety of locations for rodent MATE1, a transporter protein that mediates the final excretion step for toxic organic cations. Am J Physiol Cell Physiol. 2006 Oct;291(4):C678-86. Epub 2006 Apr 26. [Article]
- Omote H, Hiasa M, Matsumoto T, Otsuka M, Moriyama Y: The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. Trends Pharmacol Sci. 2006 Nov;27(11):587-93. Epub 2006 Sep 25. [Article]
- Tanihara Y, Masuda S, Sato T, Katsura T, Ogawa O, Inui K: Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol. 2007 Jul 15;74(2):359-71. doi: 10.1016/j.bcp.2007.04.010. Epub 2007 Apr 13. [Article]
- Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, Inui K: Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem Pharmacol. 2007 Aug 1;74(3):477-87. Epub 2007 Mar 12. [Article]
- Chen Y, Zhang S, Sorani M, Giacomini KM: Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family. J Pharmacol Exp Ther. 2007 Aug;322(2):695-700. Epub 2007 May 10. [Article]
- Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00331 Metformin approved unknown substrate Details DB00501 Cimetidine approved, investigational unknown substrateinhibitor Details DB00567 Cephalexin approved, investigational, vet_approved unknown substrate Details DB00877 Sirolimus approved, investigational no Details DB00787 Acyclovir approved unknown substrate Details DB08840 N-methylnicotinamide experimental unknown substrate Details DB12001 Abemaciclib approved, investigational unknown inhibitor Details DB12267 Brigatinib approved, investigational no inhibitor Details DB12332 Rucaparib approved, investigational no inhibitor Details DB11799 Bictegravir approved, investigational unknown inhibitor Details DB04948 Lofexidine approved, investigational no inhibitor Details DB12615 Plazomicin approved, investigational unknown inhibitor Details DB06608 Tafenoquine approved, investigational no inhibitor Details DB01333 Cefradine approved unknown substrate Details DB01137 Levofloxacin approved, investigational unknown substrateinhibitor Details DB00537 Ciprofloxacin approved, investigational unknown substrateinhibitor Details DB04574 Estrone sulfate approved unknown substrate Details DB01004 Ganciclovir approved, investigational unknown substrate Details DB08837 Tetraethylammonium experimental, investigational unknown substrate Details DB00536 Guanidine approved unknown substrate Details DB01035 Procainamide approved unknown substrate Details DB01030 Topotecan approved, investigational unknown substrateinhibitor Details DB00205 Pyrimethamine approved, investigational, vet_approved no inhibitor Details DB11753 Rifamycin approved, investigational no inhibitor Details DB09343 Tipiracil approved, investigational unknown substrate Details DB12141 Gilteritinib approved, investigational no inhibitor Details DB11978 Glasdegib approved, investigational no inhibitor Details DB13946 Testosterone undecanoate approved, investigational unknown inducer Details DB01043 Memantine approved, investigational unknown Details DB12377 Relebactam approved, investigational unknown substrate Details DB12978 Pexidartinib approved, investigational unknown inhibitor Details DB01203 Nadolol approved unknown substrate Details DB12500 Fedratinib approved, investigational unknown inhibitor Details DB11757 Istradefylline approved, investigational unknown inhibitor Details DB01195 Flecainide approved, withdrawn unknown substrateinhibitor Details DB11901 Apalutamide approved, investigational no inhibitor Details DB11732 Lasmiditan approved, investigational unknown inhibitor Details DB00879 Emtricitabine approved, investigational unknown substrate Details DB00661 Verapamil approved unknown inhibitor Details DB00927 Famotidine approved no inhibitor Details DB01018 Guanfacine approved, investigational unknown inhibitor Details DB12887 Tazemetostat approved, investigational unknown inhibitor Details DB00440 Trimethoprim approved, vet_approved unknown substrateinhibitor Details DB00243 Ranolazine approved, investigational unknown inhibitor Details DB12457 Rimegepant approved, investigational unknown inhibitor Details DB11837 Osilodrostat approved, investigational unknown inhibitor Details DB09241 Methylene blue approved, investigational unknown inhibitor Details DB11652 Tucatinib approved, investigational unknown inhibitor Details DB15102 Pemigatinib approved, investigational no inhibitor Details DB11791 Capmatinib approved, investigational unknown inhibitor Details DB15685 Selpercatinib approved, investigational unknown inhibitor Details DB14840 Ripretinib approved unknown inhibitor Details DB15305 Risdiplam approved, investigational unknown inhibitor Details DB15822 Pralsetinib approved, investigational no inhibitor Details DB14761 Remdesivir approved, investigational unknown inhibitor Details DB06137 Tirbanibulin approved, investigational no inhibitor Details DB15442 Trilaciclib approved, investigational unknown inhibitor Details DB00391 Sulpiride approved, investigational unknown substrate Details DB16628 Fosdenopterin approved unknown substrate Details DB06288 Amisulpride approved, investigational no substrateinhibitor Details DB00986 Glycopyrronium approved, investigational, vet_approved unknown substrate Details DB11886 Infigratinib approved, investigational no inhibitor Details DB15233 Avapritinib approved, investigational unknown inhibitor Details DB08930 Dolutegravir approved no inhibitor Details DB12265 Fexinidazole approved, investigational unknown inhibitor Details DB16098 Atogepant approved, investigational no inhibitor Details DB05667 Levoketoconazole approved, investigational no inhibitor Details DB09185 Viloxazine approved, investigational, withdrawn no inhibitor Details DB15133 Tepotinib approved, investigational no inhibitor Details DB11793 Niraparib approved, investigational no substrateinhibitor Details DB16267 Olutasidenib approved, investigational no inhibitor Details DB15688 Zavegepant investigational unknown substrate Details